September 16, 2025
News Provided: September 15th, 2025
nPhase, Inc., an innovator of cloud-based clinical research technology, today launched REDCap Cloud 2.0, the first industry platform to harmonize real-world evidence and clinical trial data in one system. With an interoperable architecture, the platform addresses the complex data needs of global-scale research while laying the foundation for AI adoption that will transform the future of research innovation and how life sciences organizations design, run, and analyze studies.
As clinical trials grow increasingly complex, companies must manage unprecedented volumes of diverse data. Tufts CSDD research shows that phase 3 trials generate an average of 3.6 million data points, triple the volume collected a decade ago. Real-world evidence and data (RWE/RWD) from patient forms, wearables, electronic health records, and other sources are playing a greater role in research but often come in inconsistent formats with quality gaps. Study teams must reconcile errors, duplications, and missing information while manually transferring data between systems; in fact, 55% of data managers report that reconciling data is one of their biggest burdens today.
REDCap Cloud solves these challenges by unifying disparate data sources and clinical data ecosystems into one platform, giving researchers a reliable, real-time view of trial performance. Featuring open architecture, standards-built data harmonization, and robust security, REDCap Cloud automates workflows, shortens timelines, and delivers clean, reliable, high-quality data. Notably, REDCap Cloud has already proven its effectiveness on an enterprise scale with a top 5 pharmaceutical company in a global deployment to be announced in the coming months.
“For the first time, sponsors can see how a study is performing clinically in near real-time, compressing the ‘white space’ between data collection and scientific review and enabling teams to accomplish in days what previously took months,” said Dave Sunderhaft, COO of REDCap Cloud. “REDCap Cloud 2.0 is not just an upgrade, it’s the platform our industry has been waiting for to unify all clinical data on a standards-based foundation, and proving it at enterprise scale.”
Key platform capabilities include:
Additionally, with REDCap Cloud’s purpose-built, on-platform advanced analytics capabilities, study teams now operate from a single source of truth, accelerating clinical development and enhancing collaboration across global stakeholders. This marks a tectonic shift for research, empowering researchers with a deeper, more holistic view of patients for more effective drug development and unlocking a capability researchers have never had before: understanding how therapies perform across diverse, real-world populations and disease states in real-time.
Learn more at the annual DPHARM Conference (Philadelphia, PA) Sept. 16th, 2025 and at the annual SCDM Conference (Baltimore, MD) on Sept. 28th, 2025.
Originally published on Business Wire, Sept 15th, 2025
About REDCap Cloud (nPhase, Inc.)
REDCap Cloud is an enterprise-grade clinical research data platform that integrates clinical trial and real-world evidence into a unified data layer for clinical decision-making. Purpose-built for life sciences with a foundation in security, compliance and AI-ready infrastructure, researchers can now unlock the full potential of their data.REDCap Cloud is redefining how research data is captured, harmonized, and analyzed across the global healthcare ecosystem.
For more information visit www.redcapcloud.com.
Start and migrate your trials today – scale for tomorrows novel therapies